Counterfeit drug products - example how to address this challenge by applying an holistic approach
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Presentation
- By: SCHWARZE, Stephan (Bayer Schering Pharma AG Berlin, Berlin, Germany)
The application of single isolated measures to tackle the problem of counterfeit drug products is an insufficient response to the global and fast-growing challenge of counterfeit drug products. Instead an holistic approach as part of risk management is seen to be mandatory to appropriately respond. A conceptual model encompassing the area of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.